Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 50, Issue 1, 2014, Pages 106-114

  Lu, Jingning ^a   Auduong, Linda ^a   White, Eric S ^b   Yue, Xinping ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Fibroblast; Heparan sulfate; HS6ST; Idiopathic pulmonary fibrosis; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; DISACCHARIDE; HEPARAN SULFATE; HS 6 O SULFOTRANSFERASE 1; HS 6 O SULFOTRANSFERASE 2; MESSENGER RNA; SMAD2 PROTEIN; SMALL INTERFERING RNA; SULFOTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHUS MUCOSA; CARBOHYDRATE ANALYSIS; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; IN VITRO STUDY; LUNG FIBROBLAST; LUNG FIBROSIS; MALE; MIDDLE AGED; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SULFATION; UPREGULATION;

ACTINS; BRONCHI; COLLAGEN TYPE I; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; HEPARITIN SULFATE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MIDDLE AGED; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SMAD2 PROTEIN; SULFOTRANSFERASES; UP-REGULATION;

EID: 84891753019     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0204OC     Document Type: Article

References (50)

1. Kim R, Meyer KC. Therapies for interstitial lung disease: past, present and future. Ther Adv Respir Dis 2008; 2: 319-338.
2. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174: 810-816. (Pubitemid 44511663)
3. du Bois RM. Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov 2010; 9: 129-140.
4. Zhang HY, Gharaee-Kermani M, Zhang K, Karmiol S, Phan SH. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol 1996; 148: 527-537. (Pubitemid 26056737)
5. Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 1991; 138: 1257-1265.
6. Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study. Am J Pathol 1994; 145: 114-125. (Pubitemid 24217490)
7. King TE Jr, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA Jr, Flint A, Thurlbeck W, Cherniack RM. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001; 164: 1025-1032. (Pubitemid 32971653)
8. Ramos C, Montano M, García-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 2001; 24: 591-598. (Pubitemid 32442767)
9. Suganuma H, Sato A, Tamura R, Chida K. Enhanced migration of fibroblasts derived from lungs with fibrotic lesions. Thorax 1995; 50: 984-989.
10. Larsson O, Diebold D, Fan D, Peterson M, Nho RS, Bitterman PB, Henke CA. Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS ONE 2008; 3: e3220.
11. Phan SH. The myofibroblast in pulmonary fibrosis. Chest 2002; 122 (Suppl)286S-289S. (Pubitemid 36043014)
12. Massagué J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett 2006; 580: 2811-2820.
13. Ren M, Wang B, Zhang J, Liu P, Lv Y, Liu G, Jiang H, Liu F. Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor b1. Mol Med Rep 2011; 4: 561-567.
14. Smits NC, Shworak NW, Dekhuijzen PN, van Kuppevelt TH. Heparan sulfates in the lung: structure, diversity, and role in pulmonary emphysema. Anat Rec (Hoboken) 2010; 293: 955-967.
15. Sannes PL, Wang J. Basement membranes and pulmonary development. Exp Lung Res 1997; 23: 101-108. (Pubitemid 27131799)
16. Kliment CR, Englert JM, Gochuico BR, Yu G, Kaminski N, Rosas I, Oury TD. Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem 2009; 284: 3537-3545.
17. Ruiz XD, Mlakar LR, Yamaguchi Y, Su Y, Larregina AT, Pilewski JM, Feghali-Bostwick CA. Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis. PLoS ONE 2012; 7: e43049.
18. Jiang D, Liang J, Campanella GS, Guo R, Yu S, Xie T, Liu N, Jung Y, Homer R, Meltzer EB, et al. Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. J Clin Invest 2010; 120: 2049-2057.
19. Rosenkrans WA Jr, Penney DP. Cell-cell matrix interactions in induced lung injury: II. X-irradiation mediated changes in specific basal laminar glycosaminoglycans. Int J Radiat Oncol Biol Phys 1985; 11: 1629-1637. (Pubitemid 15233625)
20. Sasaki T, Kojima S, Kubodera A. Uptake of 67Ga in the lung of mice during bleomycin treatment. Eur J Nucl Med 1984; 9: 57-61. (Pubitemid 14172899)
21. Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans finetune mammalian physiology. Nature 2007; 446: 1030-1037. (Pubitemid 46676065)
22. Yue X, Li X, Nguyen HT, Chin DR, Sullivan DE, Lasky JA. Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. J Biol Chem 2008; 283: 20397-20407.
23. Esko JD, Selleck SB. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 2002; 71: 435-471. (Pubitemid 34800227)
24. Toyoda H, Nagashima T, Hirata R, Toida T, Imanari T. Sensitive highperformance liquid chromatographic method with fluorometric detection for the determination of heparin and heparan sulfate in biological samples: application to human urinary heparan sulfate. J Chromatogr B Biomed Sci Appl 1997; 704: 19-24. (Pubitemid 28021884)
25. Yue X, Lu J, Auduong L, Sides MD, Lasky JA. Overexpression of Sulf2 in idiopathic pulmonary fibrosis. Glycobiology 2013; 23: 709-719.
26. White ES, Thannickal VJ, Carskadon SL, Dickie EG, Livant DL, Markwart S, Toews GB, Arenberg DA. Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med 2003; 168: 436-442. (Pubitemid 37046872)
27. Habuchi H, Tanaka M, Habuchi O, Yoshida K, Suzuki H, Ban K, Kimata K. The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine. J Biol Chem 2000; 275: 2859-2868. (Pubitemid 30082060)
28. Habuchi H, Miyake G, Nogami K, Kuroiwa A, Matsuda Y, Kusche- Gullberg M, Habuchi O, Tanaka M, Kimata K. Biosynthesis of heparan sulphate with diverse structures and functions: two alternatively spliced forms of human heparan sulphate 6-Osulphotransferase- 2 having different expression patterns and properties. Biochem J 2003; 371: 131-142. (Pubitemid 36458087)
29. Chilosi M, Poletti V, Murer B, Lestani M, Cancellieri A, Montagna L, Piccoli P, Cangi G, Semenzato G, Doglioni C. Abnormal reepithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63. Lab Invest 2002; 82: 1335-1345. (Pubitemid 35191537)
30. Lamanna WC, Kalus I, Padva M, Baldwin RJ, Merry CL, Dierks T. The heparanome: the enigma of encoding and decoding heparan sulfate sulfation. J Biotechnol 2007; 129: 290-307. (Pubitemid 46529030)
31. Chen L, Klass C, Woods A. Syndecan-2 regulates transforming growth factor-beta signaling. J Biol Chem 2004; 279: 15715-15718. (Pubitemid 38509254)
32. Mytilinaiou M, Bano A, Nikitovic D, Berdiaki A, Voudouri K, Kalogeraki A, Karamanos NK, Tzanakakis GN. Syndecan-2 is a key regulator of transforming growth factor beta 2/Smad2-mediated adhesion in fibrosarcoma cells. IUBMB Life 2013; 65: 134-143.
33. Kamimura K, Fujise M, Villa F, Izumi S, Habuchi H, Kimata K, Nakato H. Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene: structure, expression, and function in the formation of the tracheal system. J Biol Chem 2001; 276: 17014-17021.
34. Chen E, Stringer SE, Rusch MA, Selleck SB, Ekker SC. A unique role for 6-O sulfation modification in zebrafish vascular development. Dev Biol 2005; 284: 364-376. (Pubitemid 41188142)
35. Pratt T, Conway CD, Tian NM, Price DJ, Mason JO. Heparan sulphation patterns generated by specific heparan sulfotransferase enzymes direct distinct aspects of retinal axon guidance at the optic chiasm. J Neurosci 2006; 26: 6911-6923. (Pubitemid 44309859)
36. Qu X, Carbe C, Tao C, Powers A, Lawrence R, van Kuppevelt TH, Cardoso WV, Grobe K, Esko JD, Zhang X. Lacrimal gland development and Fgf10-Fgfr2b signaling are controlled by 2-O- and 6-O-sulfated heparan sulfate. J Biol Chem 2011; 286: 14435-14444.
37. Huynh MB, Morin C, Carpentier G, Garcia-Filipe S, Talhas-Perret S, Barbier-Chassefière V, van Kuppevelt TH, Martelly I, Albanese P, Papy-Garcia D. Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfation. J Biol Chem 2012; 287: 11363-11373.
38. Feyzi E, Saldeen T, Larsson E, Lindahl U, Salmivirta M. Age-dependent modulation of heparan sulfate structure and function. J Biol Chem 1998; 273: 13395-13398. (Pubitemid 28268375)
39. Jayson GC, Lyon M, Paraskeva C, Turnbull JE, Deakin JA, Gallagher JT. Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem 1998; 273: 51-57. (Pubitemid 28042175)
40. Waaijer CJ, de Andrea CE, Hamilton A, van Oosterwijk JG, Stringer SE, Bovée JV. Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes. Virchows Arch 2012; 461: 475-481.
41. Habuchi H, Nagai N, Sugaya N, Atsumi F, Stevens RL, Kimata K. Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality. J Biol Chem 2007; 282: 15578-15588. (Pubitemid 47093285)
42. Izvolsky KI, Lu J, Martin G, Albrecht KH, Cardoso WV. Systemic inactivation of Hs6st1 in mice is associated with late postnatal mortality without major defects in organogenesis. Genesis 2008; 46: 8-18. (Pubitemid 351413583)
43. Lyon M, Rushton G, Gallagher JT. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. J Biol Chem 1997; 272: 18000-18006. (Pubitemid 27306378)
44. Lyon M, Gallagher JT. Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol 1998; 17: 485-493. (Pubitemid 28566883)
45. López-Casillas F, Wrana JL, MassaguéJ. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 1993; 73: 1435-1444. (Pubitemid 23201155)
46. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003; 116: 217-224. (Pubitemid 36163863)
47. Leppäranta O, Sens C, Salmenkivi K, Kinnula VL, Keski-Oja J, Myllärniemi M, Koli K. Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung. Cell Tissue Res 2012; 348: 491-503.
48. Habuchi H, Kimata K. Mice deficient in heparan sulfate 6-Osulfotransferase- 1. Prog Mol Biol Transl Sci 2010; 93: 79-111.
49. Königshoff M. Lung cancer in pulmonary fibrosis: tales of epithelial cell plasticity. Respiration 2011; 81: 353-358.
50. Song K, Li Q, Peng YB, Li J, Ding K, Chen LJ, Shao CH, Zhang LJ, Li P. Silencing of hHS6ST2 inhibits progression of pancreatic cancer through inhibition of Notch signalling. Biochem J 2011; 436: 271-282.